IL6 and systemic sclerosis: Increased levels of IL-6, which can be found in the sera [24] and skin of SSc patients [31], correlate with disease severity, in particular with the extent of skin [1] and pulmonary involvement [5], and predict SSc-ILD decline and mortality [5].